- May 14, 2021
- NATIONAL CANCER CENTER AND EISAI COMMENCE JOINT RESEARCH AND DEVELOPMENT PROJECT “BASIC RESEARCH ON THE DRUG DISCOVERY AND DEVELOPMENT TO ACCELERATE DEVELOPMENT OF ANTICANCER DRUGS IN TREATMENT OF PATIENTS WITH RARE CANCERS AND REFRACTORY CANCERS”, USING PDX WITH HIGH PREDICTABILITY OF CLINICAL OUTCOMES, AND CANCER GENOME DATA
- Apr. 9, 2021
- Dr Hiroyuki Mano was awarded the 49th Fondation ARC Leopold Griffuel Prize for Clinical and Translational Cancer Research
- Nov. 25, 2020
- Hiroyoshi Nishikawa Elected AAAS Fellow
- Nov. 17, 2020
- Hiroyoshi Nishikawa Honoured with the 2020 SITC ‘Team Science Award’
- Sep. 1, 2020
- A novel biomarker for predicting clinical efficacy of PD-1 blockade therapies